ATLAS fair value
€36.69
Above fair value · 72% premium
Aedifica stock price today, ATLAS forecast and fair value
Real Estate · REIT - Healthcare Facilities · Euronext Brussels · Belgium
Prices as of Oct 27, 2026 · EUR
€36.69
Above fair value · 72% premium
55%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Aedifica's fair value at about €36.69 per share (reasonable range: €29.39 to €45.82). At €63.00, the stock trades 72% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Aedifica a 55% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €61.60 and €65.05; in 9 out of 10, between €58.70 and €68.27. Estimated annual volatility is 14%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Aedifica sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks AED.BR has traded between €60.35 and €80.05. Today it is 21.3% below that high and 4% above its low.
On the business: net margin is 132.0%; it trades at 6.3 times earnings.
Its beta is 0.94: it moves roughly in line with the market.
Aedifica NV/SA is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. 5 billion euros in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland, Spain, France, and Italy.
Want to see everything about Aedifica?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About €36.69 per share according to ATLAS (reasonable range: €29.39 to €45.82). With the stock at €63.00, it is 72% above it.
55%: close to a coin flip. In half of the simulated outcomes, AED.BR ends the month between €61.60 and €65.05.
Aedifica's market capitalization is €5.2B. Its price-to-earnings (P/E) ratio is 6.3: you pay €6.26 for each €1.00 of yearly earnings.
Yes. AED.BR's current dividend yield is 6.42% at today's price (€63.00).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy